Market Cap 90.31M
Revenue (ttm) 266.96M
Net Income (ttm) 28.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 10.68%
Debt to Equity Ratio -0.20
Volume 1,822,400
Avg Vol 1,708,078
Day's Range N/A - N/A
Shares Out 115.93M
Stochastic %K 30%
Beta 1.01
Analysts Strong Sell
Price Target $5.26

Company Profile

Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin 27. It also develops CHS-114, an investigat...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 649 3530
Address:
333 Twin Dolphin Drive, Suite 600, Redwood City, United States
Liucwpost
Liucwpost Jun. 29 at 11:39 AM
$CHRS interesting 🤞🏼🔥 Leading anti-CCR8 antibody companies, such as BMS, Ono Pharma, Coherus Biosciences, Vaccinex, Gilead Sciences, Bayer, BeOne Medicines, formerly BeiGene, and others, are developing novel anti-CCR8 antibodies that can be available in the anti-CCR8 antibody market in the coming years. https://finance.yahoo.com/news/anti-ccr8-antibodies-market-witness-213100118.html
0 · Reply
SWICH
SWICH Jun. 28 at 2:26 PM
$CHRS ChatGPT
1 · Reply
SWICH
SWICH Jun. 28 at 11:44 AM
$CHRS Looks like they filled most of those 11 or so open positions that were posted for most of 2024 and early 2025, including most of the sales roles except for that one Saints fan. Now just a few key strategic oncology positions left to fill. Interesting how specific they are with the roles' locations.
0 · Reply
Williamstock70
Williamstock70 Jun. 28 at 9:23 AM
$CHRS green??? 😮🤔
1 · Reply
neofeudal
neofeudal Jun. 28 at 1:15 AM
$CHRS So many companies far worse than this—deep in debt and with no approvals or pipeline in P1–have SPs soooo much higher. This is compressed, cheap, and will spring up. It has much of what certain players are looking for and will soon see a pump of epic proportions. I know because I’ve seen it again and again. We had, what, over a hundred million shares traded in a day not too long ago. All the stuff that makes many nervous is what these traders are looking for. Yes, big potential anyway, but as a trade, it’ll happen.
0 · Reply
Ramach
Ramach Jun. 27 at 7:36 PM
$CHRS Board, While a few of us have been extremely fortunate to enter this at the rock bottom, many have had a bitter experience of being stuck in the rut for quite a while. Every saint has a past and every sinner has a future is a well known British proverb. In the interest of maintaining integrity and avoiding any others who could benefit from the opportune timing to enter this counter, its important to thwart malicious non value add posts by all and sundry. Nobody is going to pay you if you lose, its your own money. Nobody owns bullish rights or bearish rights. Each has to suit his own pockets and do their own due diligence. Last but not least personal attacks on denny is a common theme adopted by traders across the board to swing negativity to favor their short term gambits. Just thought of posting this so that newbies will know the script/plot in play here. Macro economic clouds are slowly clearing up. So time to be alert for opportunities! #GLTA
1 · Reply
DrLotto
DrLotto Jun. 27 at 4:28 PM
$CHRS Imagine if it closes +$1 today))
1 · Reply
Rhegs
Rhegs Jun. 27 at 4:28 PM
1 · Reply
BMWLTWM3
BMWLTWM3 Jun. 27 at 2:41 PM
$CHRS give us $.66 already and retest 52 low so this can have a chance for $1 in the future.
1 · Reply
DrLotto
DrLotto Jun. 27 at 1:50 PM
$CHRS Break up or break down: place your bets:
0 · Reply
Latest News on CHRS
Coherus to Participate in Upcoming Investor Conferences

May 1, 2025, 5:04 PM EDT - 2 months ago

Coherus to Participate in Upcoming Investor Conferences


Why Is Coherus BioSciences Stock Trading Higher On Tuesday?

Dec 3, 2024, 9:34 AM EST - 7 months ago

Why Is Coherus BioSciences Stock Trading Higher On Tuesday?


Coherus Completes Divestiture of Ophthalmology Franchise

Mar 4, 2024, 1:00 AM EST - 1 year ago

Coherus Completes Divestiture of Ophthalmology Franchise


Coherus Announces U.S. Launch of LOQTORZI™

Jan 2, 2024, 8:29 AM EST - 1 year ago

Coherus Announces U.S. Launch of LOQTORZI™


Liucwpost
Liucwpost Jun. 29 at 11:39 AM
$CHRS interesting 🤞🏼🔥 Leading anti-CCR8 antibody companies, such as BMS, Ono Pharma, Coherus Biosciences, Vaccinex, Gilead Sciences, Bayer, BeOne Medicines, formerly BeiGene, and others, are developing novel anti-CCR8 antibodies that can be available in the anti-CCR8 antibody market in the coming years. https://finance.yahoo.com/news/anti-ccr8-antibodies-market-witness-213100118.html
0 · Reply
SWICH
SWICH Jun. 28 at 2:26 PM
$CHRS ChatGPT
1 · Reply
SWICH
SWICH Jun. 28 at 11:44 AM
$CHRS Looks like they filled most of those 11 or so open positions that were posted for most of 2024 and early 2025, including most of the sales roles except for that one Saints fan. Now just a few key strategic oncology positions left to fill. Interesting how specific they are with the roles' locations.
0 · Reply
Williamstock70
Williamstock70 Jun. 28 at 9:23 AM
$CHRS green??? 😮🤔
1 · Reply
neofeudal
neofeudal Jun. 28 at 1:15 AM
$CHRS So many companies far worse than this—deep in debt and with no approvals or pipeline in P1–have SPs soooo much higher. This is compressed, cheap, and will spring up. It has much of what certain players are looking for and will soon see a pump of epic proportions. I know because I’ve seen it again and again. We had, what, over a hundred million shares traded in a day not too long ago. All the stuff that makes many nervous is what these traders are looking for. Yes, big potential anyway, but as a trade, it’ll happen.
0 · Reply
Ramach
Ramach Jun. 27 at 7:36 PM
$CHRS Board, While a few of us have been extremely fortunate to enter this at the rock bottom, many have had a bitter experience of being stuck in the rut for quite a while. Every saint has a past and every sinner has a future is a well known British proverb. In the interest of maintaining integrity and avoiding any others who could benefit from the opportune timing to enter this counter, its important to thwart malicious non value add posts by all and sundry. Nobody is going to pay you if you lose, its your own money. Nobody owns bullish rights or bearish rights. Each has to suit his own pockets and do their own due diligence. Last but not least personal attacks on denny is a common theme adopted by traders across the board to swing negativity to favor their short term gambits. Just thought of posting this so that newbies will know the script/plot in play here. Macro economic clouds are slowly clearing up. So time to be alert for opportunities! #GLTA
1 · Reply
DrLotto
DrLotto Jun. 27 at 4:28 PM
$CHRS Imagine if it closes +$1 today))
1 · Reply
Rhegs
Rhegs Jun. 27 at 4:28 PM
1 · Reply
BMWLTWM3
BMWLTWM3 Jun. 27 at 2:41 PM
$CHRS give us $.66 already and retest 52 low so this can have a chance for $1 in the future.
1 · Reply
DrLotto
DrLotto Jun. 27 at 1:50 PM
$CHRS Break up or break down: place your bets:
0 · Reply
TeamDSM
TeamDSM Jun. 27 at 1:32 PM
$CHRS I have a hard time with all the investors buying down slope. Said
0 · Reply
DrLotto
DrLotto Jun. 27 at 9:15 AM
$CHRS who knows let watch
0 · Reply
DrLotto
DrLotto Jun. 27 at 8:37 AM
$CHRS https://youtu.be/Abrn8aVQ76Q?si=u-p4QBI62tE1G5YN
0 · Reply
DrLotto
DrLotto Jun. 27 at 7:55 AM
0 · Reply
DrLotto
DrLotto Jun. 27 at 7:54 AM
$CHRS who wanna in my blacklist? )))
0 · Reply
Lenano
Lenano Jun. 26 at 9:23 PM
$CHRS Unless Denny comes out with phenomenal news tomorrow, I don’t see this stop moving for the rest of the year
4 · Reply
DrLotto
DrLotto Jun. 26 at 7:27 PM
$CHRS No Filling No Beer!! 🍺
1 · Reply
shurim
shurim Jun. 26 at 6:27 PM
$CHRS im still wating just wating..... 🫠
0 · Reply
ForsakenOne
ForsakenOne Jun. 26 at 5:52 PM
$CHRS what a turd
0 · Reply
Grandgustav
Grandgustav Jun. 26 at 5:02 PM
$CHRS bought a few more today. In three years, Coherus will be one of the annoying pharma companies airing commercials during newscasts showing diverse groups of people eating tacos on outdoor outings while we hear a list of potential side-effects for the best cancer drugs on the market, ours. Then, we will be wealthy.
1 · Reply
ITrustno1
ITrustno1 Jun. 26 at 4:40 PM
$CHRS gotta keep this one under the tinfoil hat, but: MERCK owns Keytruda Bristol Myers: Opdivo The big boys PD-1’s “If” they are the shadow reason behind killing this softly via Short Plays (indirectly but on their behalf) shady shady… they have the means to dunk an $84M Market Cap Co. indefinitely, and nothing will stop them - shady MM, but legal loopholes as long as not directly linkable is one possibility. Denny and the Board do not care about the retail shareholders, period. I am a Long bag holder, 165,000 shares deep… $2.20 avg CB, have been a bull here wrongly for almost 2yrs and I’m not close to the level others on this board are bag holding losses. My conspiracy theory above, is just one thing I have to justify being wrong here. They just got rid of the product I entered into this ticket for, knew to get out before we were down to just this one product with the greatest Big Boy competition, but the SP never spiked close enough for me to exit over last few months. 😔 🧘😞
0 · Reply
Lenano
Lenano Jun. 26 at 3:53 PM
$CHRS I feel like I wasted my time and money waiting for this to pop up
2 · Reply